Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
2,761
NCT04896021
Improved Cardiovascular Disease hEALth Service Delivery in Australia: Cluster Randomised Controlled Trial (IDEAL Study)
Phase: N/A
Role: Collaborator
Start: May 26, 2021
Completion: Sep 23, 2024